Biotech: Page 32

  • Human immunodeficiency virus (HIV) viral disease vaccine under research.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    After 40 years, researchers discover new frontiers in the fight against HIV

    Medical advances in the last two decades may now provide scientists with the right toolbox to target the long-elusive virus.

    By Karissa Waddick • May 16, 2022
  • Sophia Sharp-Donaldson, executive director, Global Strategic Sourcing and Procurement, Kite Pharma
    Image attribution tooltip

    Sophia Sharp-Donaldson, executive director, Global Strategic Sourcing and Procurement, Kite Pharma and one of this year's HBA Luminary honorees. 

    Image attribution tooltip
    Opinion

    Why 'soft' skills matter in the new era of leadership

    Standout leaders honored by the Healthcare Businesswomen's Association discuss the rising value of the interpersonal approach.

    By • May 12, 2022
  • cancer R&D Explore the Trendlineâž”
    Image attribution tooltip
    Getty Images
    Image attribution tooltip
    Trendline

    Oncology R&D

    Cancer research remains a prime focus for the industry and often leads to pharma’s most impactful breakthroughs.   

    By PharmaVoice staff
  • TauRx synapse
    Image attribution tooltip
    Permission granted by TauRx
    Image attribution tooltip
    Profile

    With the shine of amyloid fading, tau is a rising star in Alzheimer's

    The tau theory in Alzheimer's is being put to the test with phase 3 trial results due later this month from TauRx Pharmaceuticals.

    By • May 11, 2022
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    In the hot pharma talent market, execs battle these recruitment misconceptions

    One of the top recruiting firms in life sciences weighs in on how companies can attract the next wave of rising stars.

    By • May 11, 2022
  • A doctor holding tablets of medicine explains options to a patient in a hospital room.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    It's time to acknowledge access as a prescribing barrier

    A new survey reveals how red tape limits patient access to doctor-preferred specialty drugs. 

    By Karissa Waddick • May 11, 2022
  • A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020 in White Oak, Maryland.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    FDA draft guidance may turn diversity in clinical trials from nice-to-have into a must-have

    New guidance from the FDA will ‘up the ante’ for diversity considerations. Here’s how your company can prepare.

    By Kelly Bilodeau • May 10, 2022
  • Replimune CEO and co-founder Philip Astley-Sparke
    Image attribution tooltip
    Permission granted by Replimune/Philip Astley-Sparke
    Image attribution tooltip

    Where hope and uncertainty meet: A cutting-edge cancer developer's winding road

    Replimune is on the precipice of a new kind of cancer treatment, but its CEO knows something about ambiguity.

    By Alexandra Pecci • May 9, 2022
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip
    Q&A // Biotech Spotlight

    Biotech Spotlight: Everest Medicines takes aim at unmet needs in Asia

    With a multi-pronged business strategy, Everest Medicines is positioning itself as a ‘rising force’ in Asian biotech.

    By • May 9, 2022
  • Close up storyboard content planning of production media of the Blogger or Vlog and the laptop and camera on the desk work.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Pharma's solution to the digital advertising dilemma? Storytelling

    Peter Shin, vice president of Client Services at Sonic Health, says quality storytelling, rather than trendy content, is central to a digital advertising strategy.

    By Karissa Waddick • May 5, 2022
  • An illustration of beta amyloid plaques and tau in the brain
    Image attribution tooltip
    National Institute on Aging. (2017). "Beta-Amyloid Plaques and Tau in the Brain" [Image]. Retrieved from Flickr.
    Image attribution tooltip

    Ultra-sensitive tests bring biomarkers into the drug development forefront

    An agreement between the biomarker assay maker Quanterix and pharma giant Eli Lilly could help discover new ways to treat Alzheimer's.

    By • May 5, 2022
  • Medication nurse wearing protective gloves get a needle ready for an injection.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip
    Profile

    Breaking new ground: Longhorn's trailblazing effort to develop a universal flu vaccine

    After years of success with their diagnostic platform for COVID-19, tuberculosis and the flu, the family funded company is shifting priorities back to the vaccine market.

    By , Karissa Waddick • May 4, 2022
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip
    Q&A

    One company's failed drug is this company's 'jewel'

    Dr. Thomas Bock, CEO of Notable, is helping the company develop a ‘new class’ of predictive precision medicines in oncology.

    By • May 2, 2022
  • Pills on money
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    The 'innovation gap' haunts Big Pharma, and the race is on for the next blockbusters

    The next big innovation wave is out there, and as pharmas expect massive losses without enough internal R&D to fill those shoes, smaller biotechs beckon.

    By • April 28, 2022
  • White mouse in laboratory
    Image attribution tooltip
    Getty Images
    Image attribution tooltip
    Profile

    Mouse vs. machine: Using AI to solve the animal testing model in pharma

    Quris is bringing its first drug tested preclinically using AI — rather than animal models — into human trials.

    By • April 26, 2022
  • Scientists examines DNA models in modern Neurological Research Laboratory.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip
    Q&A // Biotech Spotlight

    How OliX Pharmaceuticals is riding the RNAi wave

    While the company may look like “the new kid on the block,” CEO Dong-ki Lee says the Korean biotech is ready for the global stage.

    By Karissa Waddick , • April 25, 2022
  • Image attribution tooltip
    Permission granted by GoodRx
    Image attribution tooltip
    Sponsored by GoodRx

    Dispelling the 5 myths of biopharma brand planning

    Many biopharma marketers have worked for more than one company during their career. 

    April 25, 2022
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    From the fringes to the forefront — the mRNA era has taken hold of pharma

    A look at what’s next for the industry’s buzziest technology.

    By Kim Ribbink • April 22, 2022
  • This week's Woman of the Week Dr. Elisabet de los Pinos shares her life-long ambition to cure cancer in an innovative way
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Image attribution tooltip
    Podcast

    Woman of the Week: Aura Biosciences' Dr. Elisabet de los Pinos

    Dr. Elizabet de los Pinos, CEO and founder of Aura Biosciences, had a dream at a young age to change the course of cancer treatment and understand the underlying DNA of the disease.

    By • April 20, 2022
  • Entos Chief Medical Officer Steve Chen
    Image attribution tooltip
    Permission granted by Entos/Steve Chen
    Image attribution tooltip
    Profile

    With Lilly on board, Entos' medical chief champions genetic platform with 'unlimited' potential

     Steve Chen is helping to lead Entos through an ‘inflection point’ in the development of its precision medicine delivery platform.

    By Alexandra Pecci • April 14, 2022
  • An illustration of a maze inside a brain to represent Alzheimer's.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    What now? Alzheimer's drugmakers ponder the path to approval

    Why Medicare’s unprecedented decision to limit coverage for Aduhelm could have a chilling effect on Alzheimer’s R&D.

    By Kelly Bilodeau • April 14, 2022
  • This week's Woman of the Week Jill Mullan shares how she is changing the biospecimen market
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Image attribution tooltip
    Podcast

    Woman of the Week: iSpecimen's Jill Mullan

    Need biospecimens? iSpecimen aims to be the Amazon of research materials, and Jill Mullan is changing the game.

    By • April 13, 2022
  • Busy traffic in Downtown Los Angeles at dusk.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip
    Q&A

    Biotech goes Hollywood

    A few years ago, the biotech venture world in LA was almost ‘nonexistent’ — now Joseph Panetta, CEO of Biocom California, says the region is undergoing a major change.

    By • April 13, 2022
  • A technician works in a pharmaceutical manufacturing laboratory.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    'Bootcamp' helps rare disease advocates learn the ropes of drug development

    Ultragenyx’s CEO on why supporting others in rare diseases pays dividends all around.

    By Kim Ribbink • April 12, 2022
  • Purulent inflammation of the para nasal sinuses.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Optinose CEO senses big opportunities for the company's nasal delivery device

    Peter Miller explains how a repackaged sinus drug has won late-stage clinical success.

    By Jared Whitlock • April 11, 2022
  • This week's Woman of the Week Liz Homans shares how her career journey has led to this transformational moment in cancer therapeutics
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Image attribution tooltip
    Podcast

    Woman of the Week: Lyell Immunopharma's Liz Homans

    The CEO has the company poised to capitalize on its moment to address T cell exhaustion.

    By • April 6, 2022